A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
J. Zhang, Z. B. Han, Y. Liang, X. F. Zhang, Y. Q. Jin, L. F. Du, S. Shao, H. Wang, J. W. Hou, K. Xu, Z. H. Lei, Z. M. Liu, J. Zhang, Y. N. Hou, N. Liu, , Q. M. Li
This study develops a mosaic-type trimeric RBD vaccine that induces strong neutralizing antibodies against Omicron and other SARS-CoV-2 variants in rats.
bioRxiv · Mar 29, 2022Immunology